Register entry
- Registered sites
- 1
- Active NDC listings
- 17
- Labeller names
- 2
- Live patents
- 0
- Countries
- 1
- Base
- Bangladesh
Authorisation
Registered operations
Analytical testing1Labelling1Finished drug manufacture1Packaging1
Sites
Registered establishments
1| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| SQUARE PHARMACEUTICALS PLC. | Dhaka unit, Kaliakoir, Gazipur, Dhaka 1750, Bangladesh (BGD) | Analytical testing, Labelling, Finished drug manufacture, Packaging | 3003670128850366520 |
Catalogue
Drug listings by form and route
1717 active NDC listings: 17 human prescription drug. By marketing category: ANDA 17.
| Dosage form | NDCs |
|---|---|
| tablet | 8 |
| tablet, orally disintegrating | 7 |
| capsule | 1 |
| injection, solution | 1 |
| Route | NDCs |
|---|---|
| oral | 16 |
| intravenous | 1 |
| Labeller name on the listing | NDCs |
|---|---|
| square pharmaceuticals limited | 14 |
| square pharmaceuticals plc. | 3 |
Catalogue
Marketed products
17| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| Acyclovir | Acyclovir | tablet, oral | 76483-042ANDA |
| Acyclovir | Acyclovir | tablet, oral | 76483-047ANDA |
| Aripiprazole | Aripiprazole | tablet, orally disintegrating, oral | 76483-100ANDA |
| Aripiprazole | Aripiprazole | tablet, orally disintegrating, oral | 76483-101ANDA |
| Aripiprazole | Aripiprazole | tablet, orally disintegrating, oral | 76483-102ANDA |
| Aripiprazole | Aripiprazole | tablet, orally disintegrating, oral | 76483-103ANDA |
| Calcium Acetate | Calcium Acetate | capsule, oral | 76483-086ANDA |
| Mirtazapine | Mirtazapine | tablet, orally disintegrating, oral | 76483-110ANDA |
| Mirtazapine | Mirtazapine | tablet, orally disintegrating, oral | 76483-111ANDA |
| Mirtazapine | Mirtazapine | tablet, orally disintegrating, oral | 76483-112ANDA |
| Valsartan | Valsartan | tablet, oral | 76483-023ANDA |
| Valsartan | Valsartan | tablet, oral | 76483-024ANDA |
| Valsartan | Valsartan | tablet, oral | 76483-025ANDA |
| Valsartan | Valsartan | tablet, oral | 76483-026ANDA |
| calcium chloride | calcium chloride | injection, solution, intravenous | 76483-108ANDA |
| methimazole | methimazole | tablet, oral | 76483-082ANDA |
| methimazole | methimazole | tablet, oral | 76483-083ANDA |
Neighbours
Registered in the same town
2- RENATA PLCGazipur, BGD
- Eskayef Pharmaceuticals LimitedGazipur, BGD
Compare
Comparable companies in Bangladesh
- Eskayef Pharmaceuticals Limited1 site · 13 NDC
- The ACME Laboratories Ltd.1 site · 2 NDC
- RENATA PLC2 sites · 0 NDC
Enquiry
Common questions
- Is SQUARE PHARMACEUTICALS PLC. FDA approved?
- SQUARE PHARMACEUTICALS PLC. holds 1 FDA-registered establishment in Bangladesh. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are SQUARE PHARMACEUTICALS PLC.'s drugs manufactured?
- The FDA register lists Gazipur. Registered operations: analytical testing, labelling, finished drug manufacture, packaging.
- What drugs does SQUARE PHARMACEUTICALS PLC. make?
- 17 products are listed under SQUARE PHARMACEUTICALS PLC. in the openFDA NDC Directory, most often as tablet; tablet, orally disintegrating; capsule. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.